CANADIAN LEADERSHIP



As an organisation dedicated to improving the quality of life for people around the globe, Amgen fosters an inclusive environment of diverse, committed and highly accomplished people. Actual Analyst Range Consensus. Amgen takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site. In line with our values, Amgen expects everyone who works for the company — staff members, temporary staff, contractors or consultants — to conduct business ethically and in accordance with all applicable laws.

Amgen Worldwide


Globally, Amgen is a leading human therapeutics company in the biotechnology industry. For more than 35 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Founded in , Amgen has grown to be one of the world's leading independent biotechnology companies. Amgen strives to serve patients by transforming the promise of science and biotechnology into therapies that have the power to restore health or save lives. As one of the early pioneers of the biotech industry, Amgen's innovative and inspirational leadership is a core part of our social architecture.

That mission, together with our values, forms the basis of a deeply held belief system that guides our behaviours and informs our relationships. In line with our values, Amgen expects everyone who works for the company — staff members, temporary staff, contractors or consultants — to conduct business ethically and in accordance with all applicable laws.

At Amgen, we are relentless in applying the highest ethical standards to everything we do. Amgen has been the recipient of numerous awards and accolades over the years, ranging from recognition of our pioneering science and innovation, philanthropy and corporate social responsibility to our commitment to being a great place to work. For more than 35 years, Amgen has been unlocking the potential of biology for patients.

No, Return to Amgen. Letter to Our Shareholders Amgen had another successful year in , serving patients around the world with innovative medicines and enabling them to live longer, healthier lives. Read Annual Report. The Amgen Difference We are united and steadfastly focused on a single mission—helping patients.

Quick Facts Founded in , Amgen has grown to be one of the world's leading independent biotechnology companies. Data is provided "as is" for informational purposes only and is not intended for trading purposes.

SIX Financial Information a does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and b shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. Data may be intentionally delayed pursuant to supplier requirements.

Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper.

Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Fundamental company data and analyst estimates provided by FactSet. Earnings Per Share TTM A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total market value of a company.

Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple common share classes, market capitalization includes both classes. Shares Outstanding Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.

Public Float The number of shares in the hands of public investors and available to trade. To calculate, start with total shares outstanding and subtract the number of restricted shares.